How cognitive enhancement can change our duties

Frontiers in Systems Neuroscience

Volumn 8, Issue JULY, 2014, Pages

  de Sio, Filippo Santoni ^a   Faulmüller, Nadira ^a,b   Vincent, Nicole A ^a,c  

^a DELFT UNIVERSITY OF TECHNOLOGY   (Netherlands)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c GEORGIA STATE UNIVERSITY   (United States)

Author keywords

Cognitive enhancement; Ethics; Law; Mental capacity; Methylphenidate; Modafinil; Neuroenhancement; Professional duties

Indexed keywords

CAFFEINE; METHYLPHENIDATE; MODAFINIL; PHENOL; PSYCHOTROPIC AGENT;

AIRPLANE PILOT; ARTICLE; BRAIN FUNCTION; COST; DIABETES MELLITUS; EDUCATION PROGRAM; EPILEPSY; FATALITY; HUMAN; JOB PERFORMANCE; LEGAL ASPECT; MENTAL CAPACITY; MENTAL PERFORMANCE; PATIENT CARE; PHARMACOLOGICAL STIMULATION; SURGEON;

EID: 84904474341     PISSN: 16625137     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnsys.2014.00131     Document Type: Article

References (26)

1. Bostrom, N., and Sandberg, A. (2009). Cognitive enhancement: methods, ethics, regulatory challenges. Sci. Eng. Ethics 15, 311-341. doi: 10.1007/s11948-009-9142-5
2. Bublitz, J. C. (2013). "My mind is mine?! cognitive liberty as a legal concept, " in Cognitive Enhancement: An Interdisciplinary Perspective, eds E. Hildt and A. G. Franke (Dordrecht: Springer), 233-264.
3. Coffman, B. A., Clark, V. P., and Parasuraman, R. (2014). Battery powered thought: enhancement of attention, learning and memory in healthy adults using transcranial direct current stimulation. Neuroimage 85, 895-908. doi: 10.1016/j.neuroimage.2013.07.083
4. Enck, G. G. (2014). Pharmaceutical enhancement and medical professionals. Med. Health Care Philos. 17, 23-28. doi: 10.1007/s11019-013-9507-z
5. European Commission. (2011). Horizon 2020-The Framework Programme for Research and Innovation. Brussels: European Commission. http://ec.europa.eu/research/horizon2020/pdf/proposals/communication_from_the_commission_-_horizon_2020_-_the_framework_programme_for_research_and_innovation.pdf
6. Faulmüller, N., Maslen, H., and de Sio, F. S. (2013). The indirect psychological costs of cognitive enhancement. Am. J. Bioeth. 13, 45-47. doi: 10.1080/15265161.2013.794880
7. Förstl, H. (2009). Neuro-enhancement. Brain doping. Nervenarzt 80, 840-846. doi: 10.1007/s00115-009-2801-6
8. Gawande, A. (2012). Two hundred years of surgery. N. Engl. J. Med. 366, 1716-1723. doi: 10.1056/NEJMra1202392
9. Gilleena, J., Michalopouloua, P. G., Reichenberg, A., Drake, R., Wykes, T., Lewis, S. W., et al. (2014). Modafinil combined with cognitive training is associated with improved learning in healthy volunteers-A randomised controlled trial. Eur. Neuropsychopharmacol. 24, 529-539. doi: 10.1016/j.euroneuro.2014.01.001
10. Goold, I., and Maslen, H. (2014). Must the surgeon take the pill? Negligence duty in the context of cognitive enhancement. Mod. Law Rev. 77, 60-86. doi: 10.1111/1468-2230.12056
11. Husain, M., and Mehta, M. A. (2011). Cognitive enhancement by drugs in health and disease. Trends Cogn. Sci. 15, 28-36. doi: 10.1016/j.tics.2010.11.002
12. Madras, B. K., Xie, Z., Xie, Z., Lin, Z., Jassen, A., Panas, H., et al. (2006). Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro. J. Pharmacol. Exp. Ther. 319, 561-569. doi: 10.1124/jpet.106.106583
13. Maslen, H., Faulmüller, N., and Savulescu, J. (2014). Pharmacological cognitive enhancement-how neuroscientific research could advance ethical debate. Front. Syst. Neurosci. 8:107. doi: 10.3389/fnsys.2014.00107
14. Maslen, H., Santoni de Sio, F., and Faulmüller, N. (in press). "With cognitive enhancement comes great responsibility?, " in Responsible Innovation (Vol. 2), ed B. J. Koops (Dordrecht: Springer Verlag).
15. Meinzer, M., Jähnigen, S., Copland, D. A., Darkow, R., Grittner, U., Avirame, K., et al. (2014). Transcranial direct current stimulation over multiple days improves learning and maintenance of a novel vocabulary. Cortex 50, 137-147. doi: 10.1016/j.cortex.2013.07.013
16. Moor, J. H. (2008). "Why we need better ethics for emerging technologies, " in Information Technology and Moral Philosophy, eds J. van den Hoven and J. Weckert (New York: Cambridge University Press), 26-39.
17. Queensland Health. (2009). Fatigue Risk Management System: Resource Pack. Brisbane, QLD, Australia. http://www.health.qld.gov.au/qhpolicy/docs/imp/qh-imp-358-1.pdf
18. Repantis, D., Schlattmann, P., Laisney, O., and Heuser, I. (2010). Modafinil and methylphenidate for neuroenhancement in healthy individuals: a systematic review. Pharmacol. Res. 62, 187-206. doi: 10.1016/j.phrs.2010.04.002
19. Sandel, M. J. (2009). The Case Against Perfection. Cambridge, MA: Harvard University Press.
20. Santoni de Sio, F., Faulmüller, N., Savulescu, J., and Vincent, N. A. (in press). "Why less praise for enhanced performance? Moving beyond responsibility-shifting, authenticity and cheating to a nature of activities approach, " in Cognitive Enhancement: Ethical and Policy Implications in International Perspectives, eds F. Jotterand and V. Dubljevic (Oxford: Oxford University Press).
21. Santoni de Sio, F., Robichaud, P., and Vincent, N. A. (2014). Who should enhance? Conceptual and normative dimensions of cognitive enhancement. Humanamente J. Philos. Stud. 26, 179-197.
22. Schelle, K. J., Faulmüller, N., Caviola, L., and Hewstone, M. (2014). Attitudes towards pharmacological cognitive enhancement-a review. Front. Syst. Neurosci. 8:53. doi: 10.3389/fnsys.2014.00053
23. van den Hoven, J. (2013). "Value sensitive design and responsible innovation, " in Responsible Innovation-Managing the Responsible Emergence of Science and Innovation in Society, eds R. Owen, J. Bessant and M. Heintz (West Sussex: John Wiley), 75-84.
24. Vincent, N. (2011). "The challenges posed to private law by emerging cognitive enhancement technologies, " in The Law of the Future and The Future of Law, eds S. Muller, S. Zouridis, M. Frishman and L. Kistemaker (Oslo: Torkel Opsahl Academic EPublisher), 511-521. http://www.fichl.org/fileadmin/fichl/documents/FICHL_11_Web.pdf
25. Vincent, N. (2013). "Enhancing responsibility, " in Neuroscience and Legal Responsibilty, ed N. A. Vincent (New York, NY: Oxford University Press), 305-336.
26. Volkow, N. D., Fowler, J. S., Logan, J., Alexoff, D., Zhu, W., Telang, F., et al. (2009). Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications. JAMA 301, 1148-1154. doi: 10.1001/jama.2009.351